Atea Pharmaceuticals, Inc. (AVIR) Financial Statements (2026 and earlier)

Company Profile

Business Address 225 FRANKLIN STREET
BOSTON, MA 02110
State of Incorp. MA
Fiscal Year End December 31
Industry (SIC) 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)
Annual | Quarterly

3/31/2026
MRQ
12/31/2025
12/31/2024
12/31/2023
12/31/2022
12/31/2021
12/31/2020
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments, including:301,830454,700578,100646,709764,375850,117
Cash and cash equivalent95,71364,696143,823188,460764,375850,117
Short-term investments206,117390,025434,283458,249  
Other undisclosed cash, cash equivalents, and short-term investments  (21)(6)   
Receivables      5,815
Other undisclosed current assets9,1617,65512,35514,2138,0287,545
Total current assets:310,991462,355590,455660,922772,403863,477
Noncurrent Assets
Operating lease, right-of-use asset6341,2431,8282,389  
Property, plant, and equipment, after accumulated depreciation, depletion, and amortization4578731,2891,7052348
Restricted cash and investments    198  
Other noncurrent assets3,1361971,3961,494466107
Total noncurrent assets:4,2272,3134,5135,786489155
TOTAL ASSETS:315,218464,668594,968666,708772,892863,632
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities19,38310,3629,9489,10911,3152,803
Taxes payable✕✕✕✕✕2,572 
Employee-related liabilities✕✕✕✕✕4,2092,743
Accounts payable12,9454,4584,2522,5514,53460
Accrued liabilities6,4385,9045,6966,558  
Deferred revenue      301,367
Other undisclosed current liabilities20,4018,24122,4289,36945,56811,625
Total current liabilities:39,78418,60332,37618,47856,883315,795
Noncurrent Liabilities
Liabilities, other than long-term debt  7,1987,4007,6585,93236
Accounts payable and accrued liabilities  6,3565,7585,255  
Other liabilities     5,93236
Operating lease, liability  8421,6422,403  
Total noncurrent liabilities:  7,1987,4007,6585,93236
Total liabilities:39,78425,80139,77626,13662,815315,831
Equity
Equity, attributable to parent275,434438,867555,192640,572710,077547,801
Common stock788483838382
Additional paid in capital797,751802,770750,737701,052653,964612,879
Accumulated other comprehensive income (loss)174233207(684)  
Retained earnings (accumulated deficit)(522,569)(364,220)(195,835)(59,879)56,030(65,160)
Total equity:275,434438,867555,192640,572710,077547,801
TOTAL LIABILITIES AND EQUITY:315,218464,668594,968666,708772,892863,632

Income Statement (P&L) ($ in thousands)
Annual | Quarterly

3/31/2026
TTM
12/31/2025
12/31/2024
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Revenues     351,36748,633
Gross profit:     351,36748,633
Operating expenses(180,887)(192,950)(164,162)(130,650)(212,990)(59,663)
Operating income (loss):(180,887)(192,950)(164,162)(130,650)138,377(11,030)
Income (loss) from continuing operations before equity method investments, income taxes:(180,887)(192,950)(164,162)(130,650)138,377(11,030)
Other undisclosed income from continuing operations before income taxes16,37625,49029,22411,151213 
Income (loss) from continuing operations before income taxes:(164,511)(167,460)(134,938)(119,499)138,590(11,030)
Income tax expense (benefit)6,162(925)(1,018)3,590(17,400) 
Income (loss) from continuing operations:(158,349)(168,385)(135,956)(115,909)121,190(11,030)
Income (loss) before gain (loss) on sale of properties:✕✕✕✕✕121,190(11,030)
Other undisclosed net income      83
Net income (loss) available to common stockholders, diluted:(158,349)(168,385)(135,956)(115,909)121,190(10,947)

Comprehensive Income ($ in thousands)
Annual | Quarterly

3/31/2026
TTM
12/31/2025
12/31/2024
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Net income (loss):(158,349)(168,385)(135,956)(115,909)121,190(10,947)
Other comprehensive income (loss)(59)26891(684)  
Other undisclosed comprehensive loss      
Comprehensive income (loss):(158,408)(168,359)(135,065)(116,593)121,190(10,947)
Other undisclosed comprehensive loss, net of tax, attributable to parent      
Comprehensive income (loss), net of tax, attributable to parent:(158,408)(168,359)(135,065)(116,593)121,190(10,947)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: